Synthetic carbohydrate-binding agents neutralize SARS-CoV-2 by inhibiting binding of the spike protein to ACE2

Summary: Developing strategies against the SARS-CoV-2 is currently a main research subject. SARS-CoV-2 infects host cells by binding to human ACE2 receptors. Both, virus and ACE2, are highly glycosylated, and exploiting glycans of the SARS-CoV-2 envelope as binding sites for ACE2 represents a virus...

Full description

Bibliographic Details
Main Authors: Oscar Francesconi, Lorena Donnici, Marco Fragai, Elisa Pesce, Mauro Bombaci, Alessandra Fasciani, Lara Manganaro, Matteo Conti, Renata Grifantini, Raffaele De Francesco, Cristina Nativi, Stefano Roelens
Format: Article
Language:English
Published: Elsevier 2022-05-01
Series:iScience
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004222005090
_version_ 1811339895890771968
author Oscar Francesconi
Lorena Donnici
Marco Fragai
Elisa Pesce
Mauro Bombaci
Alessandra Fasciani
Lara Manganaro
Matteo Conti
Renata Grifantini
Raffaele De Francesco
Cristina Nativi
Stefano Roelens
author_facet Oscar Francesconi
Lorena Donnici
Marco Fragai
Elisa Pesce
Mauro Bombaci
Alessandra Fasciani
Lara Manganaro
Matteo Conti
Renata Grifantini
Raffaele De Francesco
Cristina Nativi
Stefano Roelens
author_sort Oscar Francesconi
collection DOAJ
description Summary: Developing strategies against the SARS-CoV-2 is currently a main research subject. SARS-CoV-2 infects host cells by binding to human ACE2 receptors. Both, virus and ACE2, are highly glycosylated, and exploiting glycans of the SARS-CoV-2 envelope as binding sites for ACE2 represents a virus strategy for attacking the human host. We report here that a family of mannose-binding synthetic carbohydrate-binding agents (CBAs) inhibits SARS-CoV-2 infection, showing broad neutralizing activity vs. several variants of the spike protein. Preliminary tests indicated that the investigated CBAs interact with the spike protein rather than with ACE2. For a lead compound (IDS060), which has been selected among others for its lack of cytotoxicity, evidence of binding to the RBD of the spike protein has been found by NMR experiments, while competitive binding assays in the presence of IDS060 showed inhibition of binding of RBD to hACE2, although neutralizing activity was also observed with variants showing reduced or depleted binding.
first_indexed 2024-04-13T18:34:14Z
format Article
id doaj.art-714c1c36152045e78a22d088d37e8025
institution Directory Open Access Journal
issn 2589-0042
language English
last_indexed 2024-04-13T18:34:14Z
publishDate 2022-05-01
publisher Elsevier
record_format Article
series iScience
spelling doaj.art-714c1c36152045e78a22d088d37e80252022-12-22T02:34:58ZengElsevieriScience2589-00422022-05-01255104239Synthetic carbohydrate-binding agents neutralize SARS-CoV-2 by inhibiting binding of the spike protein to ACE2Oscar Francesconi0Lorena Donnici1Marco Fragai2Elisa Pesce3Mauro Bombaci4Alessandra Fasciani5Lara Manganaro6Matteo Conti7Renata Grifantini8Raffaele De Francesco9Cristina Nativi10Stefano Roelens11Dipartimento di Chimica, DICUS, University of Florence, Florence, ItalyFondazione INGM - Istituto Nazionale Genetica Molecolare “Romeo ed Enrica Invernizzi”, Milan, ItalyDipartimento di Chimica, DICUS, University of Florence, Florence, Italy; CERM, University of Florence, Florence, ItalyFondazione INGM - Istituto Nazionale Genetica Molecolare “Romeo ed Enrica Invernizzi”, Milan, ItalyFondazione INGM - Istituto Nazionale Genetica Molecolare “Romeo ed Enrica Invernizzi”, Milan, ItalyFondazione INGM - Istituto Nazionale Genetica Molecolare “Romeo ed Enrica Invernizzi”, Milan, ItalyFondazione INGM - Istituto Nazionale Genetica Molecolare “Romeo ed Enrica Invernizzi”, Milan, Italy; Dipartimento di Scienze Farmacologiche e Biomolecolari, University of Milan, Milan, ItalyFondazione INGM - Istituto Nazionale Genetica Molecolare “Romeo ed Enrica Invernizzi”, Milan, ItalyFondazione INGM - Istituto Nazionale Genetica Molecolare “Romeo ed Enrica Invernizzi”, Milan, Italy; Corresponding authorFondazione INGM - Istituto Nazionale Genetica Molecolare “Romeo ed Enrica Invernizzi”, Milan, Italy; Dipartimento di Scienze Farmacologiche e Biomolecolari, University of Milan, Milan, Italy; Corresponding authorDipartimento di Chimica, DICUS, University of Florence, Florence, Italy; Corresponding authorINSTM, University of Florence, Florence, ItalySummary: Developing strategies against the SARS-CoV-2 is currently a main research subject. SARS-CoV-2 infects host cells by binding to human ACE2 receptors. Both, virus and ACE2, are highly glycosylated, and exploiting glycans of the SARS-CoV-2 envelope as binding sites for ACE2 represents a virus strategy for attacking the human host. We report here that a family of mannose-binding synthetic carbohydrate-binding agents (CBAs) inhibits SARS-CoV-2 infection, showing broad neutralizing activity vs. several variants of the spike protein. Preliminary tests indicated that the investigated CBAs interact with the spike protein rather than with ACE2. For a lead compound (IDS060), which has been selected among others for its lack of cytotoxicity, evidence of binding to the RBD of the spike protein has been found by NMR experiments, while competitive binding assays in the presence of IDS060 showed inhibition of binding of RBD to hACE2, although neutralizing activity was also observed with variants showing reduced or depleted binding.http://www.sciencedirect.com/science/article/pii/S2589004222005090Biological sciencesCarbohydrateMicrobiology
spellingShingle Oscar Francesconi
Lorena Donnici
Marco Fragai
Elisa Pesce
Mauro Bombaci
Alessandra Fasciani
Lara Manganaro
Matteo Conti
Renata Grifantini
Raffaele De Francesco
Cristina Nativi
Stefano Roelens
Synthetic carbohydrate-binding agents neutralize SARS-CoV-2 by inhibiting binding of the spike protein to ACE2
iScience
Biological sciences
Carbohydrate
Microbiology
title Synthetic carbohydrate-binding agents neutralize SARS-CoV-2 by inhibiting binding of the spike protein to ACE2
title_full Synthetic carbohydrate-binding agents neutralize SARS-CoV-2 by inhibiting binding of the spike protein to ACE2
title_fullStr Synthetic carbohydrate-binding agents neutralize SARS-CoV-2 by inhibiting binding of the spike protein to ACE2
title_full_unstemmed Synthetic carbohydrate-binding agents neutralize SARS-CoV-2 by inhibiting binding of the spike protein to ACE2
title_short Synthetic carbohydrate-binding agents neutralize SARS-CoV-2 by inhibiting binding of the spike protein to ACE2
title_sort synthetic carbohydrate binding agents neutralize sars cov 2 by inhibiting binding of the spike protein to ace2
topic Biological sciences
Carbohydrate
Microbiology
url http://www.sciencedirect.com/science/article/pii/S2589004222005090
work_keys_str_mv AT oscarfrancesconi syntheticcarbohydratebindingagentsneutralizesarscov2byinhibitingbindingofthespikeproteintoace2
AT lorenadonnici syntheticcarbohydratebindingagentsneutralizesarscov2byinhibitingbindingofthespikeproteintoace2
AT marcofragai syntheticcarbohydratebindingagentsneutralizesarscov2byinhibitingbindingofthespikeproteintoace2
AT elisapesce syntheticcarbohydratebindingagentsneutralizesarscov2byinhibitingbindingofthespikeproteintoace2
AT maurobombaci syntheticcarbohydratebindingagentsneutralizesarscov2byinhibitingbindingofthespikeproteintoace2
AT alessandrafasciani syntheticcarbohydratebindingagentsneutralizesarscov2byinhibitingbindingofthespikeproteintoace2
AT laramanganaro syntheticcarbohydratebindingagentsneutralizesarscov2byinhibitingbindingofthespikeproteintoace2
AT matteoconti syntheticcarbohydratebindingagentsneutralizesarscov2byinhibitingbindingofthespikeproteintoace2
AT renatagrifantini syntheticcarbohydratebindingagentsneutralizesarscov2byinhibitingbindingofthespikeproteintoace2
AT raffaeledefrancesco syntheticcarbohydratebindingagentsneutralizesarscov2byinhibitingbindingofthespikeproteintoace2
AT cristinanativi syntheticcarbohydratebindingagentsneutralizesarscov2byinhibitingbindingofthespikeproteintoace2
AT stefanoroelens syntheticcarbohydratebindingagentsneutralizesarscov2byinhibitingbindingofthespikeproteintoace2